Hangzhou Evegen Biotech Co., Ltd. is an R&D-driven biotech company with a highly experienced technical team specializing in genetic engineering and IVD immunoassay. We have well-established veterinary drug GMP facilities and biosafety level-II laboratories. All production activities are under control of ISO9001. ISO14001 and ISO45001.
Through our global brand VETDiagnostix, we provide rapid, accurate diagnostic solutions for veterinarians treating companion animals, livestock, equine, and exotic species (birds, reptiles, and rabbits). We also offer an easy-to-use rapid test reader for both qualitative and quantitative analysis of lateral flow immunoassay results.
Unlike other industry peers, we maintain complete in-house development of core immunoassay materials, giving us unique control over product quality and innovation. Our scientific team demonstrates industry-leading R&D efficiency, consistently achieving accelerated development cycles without compromising performance. We employ a market-driven approach, focusing on genuine clinical needs to develop tailored, localized diagnostic solutions. Notably, we possess specialized expertise in zoonotic disease diagnostics, with a proven track record of designing high-performance assays for these challenging pathogens
company strength
1
Factory Area
The company occupies an area of over 5,000 square meters.
2
Production Capacity
With 55 precision-controlled cleanrooms and production lines, we maintain a robust daily output of 100,000 diagnostic units.
3
R&D Capability
With 10 years of experience and close collaboration with research institutions and universities, Evegen drives continuous innovation in animal disease diagnostics.
4
After-sales Service
We offer comprehensive technical support and product training to ensure long-term partnership success.
Factory Tour
Evegen's state-of-the-art manufacturing facility operates under strict veterinary GMP standards and triple ISO certifications (9001/14001/45001). Housing 55 precision-controlled cleanrooms and advanced production lines, we deliver a robust daily capacity of 100,000 diagnostic units - ensuring both quality and scalability for global partners
Laboratory
Evegen takes technological innovation as its core competitiveness. The R&D team possesses strong capabilities in IVD technologies such as immunochromatography and enzyme-linked immunosorbent assay (ELISA), as well as top-tier expertise in biological raw material technologies including monoclonal antibodies, polyclonal antibodies, genetic recombination, and synthetic antigens. Maintaining close collaboration with research institutions, universities, and industry partners, Evegen continuously drives rapid advancements in the field of animal disease diagnostics.
Warehouse
We conduct 100% inspection on all incoming raw materials, in-process quality checks during production, and 100% final inspection before shipment to ensure every product delivered to customers meets the highest quality standards.
